T 1217/12 (Extending the duration of on-time in dopamin replacement therapy/ … of 7.6.2018

European Case Law Identifier: ECLI:EP:BA:2018:T121712.20180607
Date of decision: 07 June 2018
Case number: T 1217/12
Application number: 01976536.1
IPC class: A61K 31/00
A61K 31/136
A61K 31/353
A61K 31/495
A61P 25/16
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 241 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: TREATMENT OF MOTOR FLUCTUATIONS WITH 5-HYDROXYTRYPTAMINE 1A RECEPTOR ACTIVITY ENHANCING COMPOUNDS
Applicant name: Motac Neuroscience Limited
Opponent name: Abbott Healthcare Products B.V.
Merz Pharma GmbH & Co. KGaA
Board: 3.3.01
Headnote: -
Relevant legal provisions:
European Patent Convention R 84(1)
European Patent Convention R 100(1)
Keywords: Lapse of patent in all designated states - continuation of appeal proceedings (no)
Catchwords:

-

Cited decisions:
T 0708/01
Citing decisions:
-

Summary of Facts and Submissions

I. The patent proprietor (appellant) lodged an appeal against the interlocutory decision of the opposition division on the amended form in which European patent No. 1 339 398 could be maintained.

II. By communication of the board of 6 March 2018, sent by registered letter with advice of delivery to the appellant, the parties' attention was drawn to the fact that the patent had lapsed in all designated contracting states. The appellant was asked to inform the board within a time limit of two months whether it requested a continuation of the appeal proceedings.

III. The appellant, who received the communication, did not reply within the given time limit.

Reasons for the Decision

1. If a European patent has lapsed in all designated contracting states, opposition proceedings may be continued at the request of the opponent (Rule 84(1) EPC). Pursuant to Rule 100(1) EPC, this also applies in appeal proceedings following opposition proceedings. However, if, as in the present case, the patent proprietor is the appellant, it would be inappropriate to allow the opponent (respondent) to decide whether the appeal proceedings shall be continued. For this reason, Rule 84(1) EPC has to be applied mutatis mutandis in such opposition appeal proceedings, so that it is the patent proprietor who can request that appeal proceedings be continued (see T 708/01, point 1 of the Reasons).

2. The appellant did not file any request with respect to the continuation of appeal proceedings within the given time limit. This is interpreted as meaning that the appellant did not wish to request continuation. In these circumstances, the board sees no reason to continue the appeal proceedings of its own motion. Therefore, the appeal proceedings are terminated.

Order

For these reasons it is decided that:

The appeal proceedings are terminated.

Quick Navigation